[PMC free article] [Google Scholar] Diagnosis: Torsades de pointes ventricular tachycardia presumably resulting from hydroxychloroquine therapy
Figure created in Biorender Hydroxychloroquine (HCQ) has been shown to be at least somewhat effective in treating patients with coronavirus disease 2019 (COVID-19)
Medicine reconciliation and careful monitoring of QTc may help prevent cardiac complications in patients with COVID-19 treated with hydroxychloroquine
Background: Among many drugs that hold potential in COVID-19 pandemic, chloroquine (CQ), and its derivative hydroxychloroquine (HCQ) have generated unusual interest
2 We report an interesting case of corrected QT (QTc) prolongation and torsades de pointes in a patient with SARS-CoV-2 (COVID-19) pneumonia, provoked by therapy with multiple QTc-prolonging medications
2021 Mar;35 (3):954-955
The magnitude of QT prolongation may increase with increasing concentrations of the drug
Hydroxychloroquine is not recommended in patients taking other drugs that have the potential to prolong the QT interval or are arrhythmogenic as life-threatening additive effects on the QT Background: Hydroxychloroquine (HCQ) is used for treatment of lupus erythematosus
Introduction In contrast to torsades de pointes, QT prolongation had 45
doi: 10
2020 Jun;26(6):808-809
Hydroxychloroquine is not recommended in patients taking other drugs that have the potential to prolong the QT interval or are arrhythmogenic as life-threatening additive effects on the QT Interaction Summary
QT-prolongation is a commonly used surrogate marker for the risk of torsades de pointes and other arrythmias
Medicine reconciliation and careful monitoring of QTc may help prevent cardiac complications in patients with COVID-19 treated with hydroxychloroquine
Ventricular arrhythmias (including torsades de pointes) have been reported in hydroxychloroquine sulfate tablets-treated patients
QT prolongation, torsades de pointes, Hydroxychloroquine has been used for rheumatological diseases for many decades and is considered a safe medication
2020; 17:1472-1479
La substitution du groupe hydroxyéthyl au groupement éthyl sur la chaîne latérale de la 4-amino-quinoléine confère à l'hydroxychloroquine une action anti-inflammatoire et antalgique
Sign in | Create an account
Ventricular arrhythmias (including torsades de pointes) have been reported in hydroxychloroquine sulfate-treated patients
Despite this, she continued to have runs of torsades
Medicine reconciliation and careful monitoring of QTc may help prevent cardiac complications in patients with COVID-19 treated with hydroxychloroquine
QT-prolongation is a commonly used surrogate marker for the risk of torsades de pointes and other arrythmias
Hydroxychloroquine, QTc prolongation and risk of torsades de pointes DOI: Authors: Sarah Subhan Andy Wang Subo Dey Wei Tang Show all 5 authors
The World Health Organization has announced that it has temporarily halted the
hydroxychloroquine–azithromycin therapy versus matched controls Higher degree of corrected QT (QTc) prolongation was observed in the patients treated with
Medicine reconciliation and careful monitoring of QTc may help prevent cardiac complications in patients with COVID-19 treated with
1452-1455
Among many drugs that hold potential in COVID-19 pandemic, chloroquine (CQ), and its derivative hydroxychloroquine (HCQ) have generated unusual interest
Hydroxychloroquine has been associated with QT interval prolongation, ventricular premature contractions, and torsades de pointes
The World Health Organization has announced that it has temporarily halted the hydroxychloroquine arm of its Solidarity trial
Medicine reconciliation and careful monitoring of QTc may help prevent cardiac complications in patients with COVID-19 treated with hydroxychloroquine
Published guidance documents vary in their recommendations for monitoring and managing these potential
1053/j
There was significant greater reporting of prolonged-QT (LQT) and/or ventricular tachycardia including
It is hoped that with appropriate risk stratification and monitoring, the incidence of drug-induced TdP will be significantly diminished
1016/j
Hydroxychloroquine has been associated with QT interval prolongation, ventricular premature contractions, and torsades de pointes
Drug induced QT prolongation and torsades de pointes Heart
com; PMID: 14594906 PMCID: The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin